Brook I
Uniformed Services University of the Health Sciences, Bethesda, Maryland.
Adv Pediatr. 1987;34:357-77.
Bacteroides sp (Bacteroides melaninogenicus, Bacteroides oralis, and Bacteroides fragilis), peptostreptococci, and fusobacteria are important pathogens in respiratory tract infections (RTI). These organisms are often recovered mixed with other aerobic, facultative, and anaerobic bacteria. Evidence supporting their virulence is provided by studies showing their synergistic potentials in mixed infections and their increased virulence when encapsulated. A recent increase in numbers of beta-lactamase producing strains of anaerobic gram-negative bacteria in RTI has been associated with increased failure rates of penicillins in eradication of these infections. These infections include chronic otitis media, chronic sinusitis and mastoiditis, chronic recurrent tonsillitis, and lung abscesses. The pathogenicity of these organisms is apparent through their ability not only to survive penicillin therapy but also to protect penicillin susceptible pathogens from that drug. These direct and indirect virulence characteristics of anaerobic bacteria require the administration of appropriate antimicrobial therapy directed against all pathogens in mixed infections. The synergy that exists between different aerobic and anaerobic organisms in the respiratory tract is due to several pathogenic mechanisms. These mechanisms include the production of a capsule, which protects organisms from phagocytosis, and the production of beta-lactamase, which inactivates penicillins and first-generation cephalosporins. Both of these mechanisms enhance infection and induce complications. However, more work is necessary to prevent encapsulation and the production of enzymes. Data, thus far, indicate that there are therapeutic modalities that can be used to prevent these occurrences and eliminate many mixed RTI.
拟杆菌属(产黑素拟杆菌、口腔拟杆菌和脆弱拟杆菌)、消化链球菌和梭杆菌是呼吸道感染(RTI)中的重要病原体。这些微生物常常与其他需氧菌、兼性厌氧菌和厌氧菌混合检出。显示它们在混合感染中具有协同作用以及包膜化后毒力增强的研究为其毒力提供了证据。呼吸道感染中近期产生β-内酰胺酶的厌氧革兰阴性菌数量增加,与青霉素根除这些感染的失败率上升有关。这些感染包括慢性中耳炎、慢性鼻窦炎和乳突炎、慢性复发性扁桃体炎以及肺脓肿。这些微生物的致病性不仅体现在它们能够在青霉素治疗下存活,还体现在它们能够保护对青霉素敏感的病原体免受该药物的影响。厌氧菌的这些直接和间接毒力特性要求针对混合感染中的所有病原体给予适当的抗菌治疗。呼吸道中不同需氧菌和厌氧菌之间存在的协同作用归因于多种致病机制。这些机制包括产生保护微生物免受吞噬作用的荚膜,以及产生使青霉素和第一代头孢菌素失活的β-内酰胺酶。这两种机制都会加重感染并引发并发症。然而,需要开展更多工作来防止荚膜形成和酶的产生。迄今为止的数据表明,有一些治疗方法可用于预防这些情况并消除许多混合性呼吸道感染。